إعلان
إعلان
CTXR
Citius Pharmaceuticals Inc. Common
0.88
USDبرعاية
-0.02
-2.56%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
0.87
-0.01
-0.80%
تقارير أرباح CTXR
النسبة الإيجابية المفاجئة
CTXR تفوق 9 من 26 آخر التقديرات.
35%
التقرير التالي
بيانات التقرير القادم
١٢ فبراير ٢٠٢٦
Estimate for Q1 26 (Revenue/ EPS)
$3.52M
/-$0.01
التغير الضمني من Q4 25 (Revenue/ EPS)
--
/--
التغير الضمني من Q1 25 (Revenue/ EPS)
--
/-99.23%
Citius Pharmaceuticals Inc. Common earnings per share and revenue
On ٢٦ ديسمبر ٢٠٢٥, CTXR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.87 مليون, with a -100.00% difference. The market reacted with a -1.69% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 المحللين forecast an EPS of -0.01 USD, with revenue projected to reach 3.52 مليون USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Citius Pharmaceuticals Inc. Common's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Citius Pharmaceuticals Inc. Common reported EPS of --, missing estimates by --, and revenue of $0.00, -100% below expectations.
How did the market react to Citius Pharmaceuticals Inc. Common's Q4 2025 earnings?
The stock price moved down -1.69%, changed from $0.84 before the earnings release to $0.83 the day after.
When is Citius Pharmaceuticals Inc. Common expected to report next?
The next earning report is scheduled for ١٢ فبراير ٢٠٢٦.
What are the forecasts for Citius Pharmaceuticals Inc. Common's next earnings report?
Based on 3
المحللين, Citius Pharmaceuticals Inc. Common is expected to report EPS of -$0.01 and revenue of $3.52M for Q1 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان